Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
PDF) Unmasking Integration Challenges: The Case of Biogal's Acquisition by Teva Pharmaceutical Industries